Aeolus Pharmaceuticals Publications and Patents

Publications

	An Orally Active Catalytic Metalloporphyrin Protects against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity In Vivo
	Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster
	ß-amyloid 42 accumulation in the lumbar spinal cord motor neurons of amyotrophic lateral sclerosis patients
	Manganese Porphyrin Given at Symptom Onset Markedly Extends Survival of ALS Mice
	Catalytic antioxidants: a radical approach to new therapeutics
	Relevance of oxidative injury in the pathogenesis of motor neuron diseases

Patents

Patent No.: US 6,479,477 B1 [.pdf]

Patent No.: US 6,544,975 B1 [.pdf]

Patent No.: US 6,916,799 B1 [.pdf]